The drugmaker will reduce its workforce by offering employees a financial incentive to voluntarily resign.
Eli Lilly employs about 1,400 people at the plant, which produces insulin and oncology drugs.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
Register to Attend Webinar
Presenters:
Calvin Hunsicker, SureCost|Kelly Cicero, SureCost
Next Up in Pharmacy
-
A September 2026 American Medical Association Policy Research Perspective analyzed Decision Resources Group data on PBM and insurer market shares…
-
It’s the end of the world as we know it; panic and mass hysteria. That is roughly the tone of…
-
The FDA has approved Emcitate (tiratricol) to treat peripheral thyrotoxicosis in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
